Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
Recruiting
N/A
Interventional Study
Sepsis
Sepsis Mrsa
Sepsis Bacteremia
Antimicrobial - Induced Nephropathy
Sepsis, Severe
Septic Shock
Septic Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 52,500 (estimated)
- Sponsor
- Children's Hospital of Philadelphia · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this quasi-experimental interventional study is to determine the effectiveness of a multifaceted stewardship intervention in reducing overall vancomycin use in five tertiary care Pediatric Intensive Care Units (PICU).
There are two groups of subjects in this study: PICU clinicians/sepsis stakeholders and patients admitted to one of the participating PICUs during the study period. The …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Patient Inclusion Criteria:
* Admitted to one of the participating PICUs during the study period
Patient Exclusion Criteria:
* None
Clinician Inclusion Criteria:
1. PICU prescribing clinician (including attending physicians, fellows, residents, nurse practitioners, and physician assistants) OR …
Contacts